We have previously reported that blockage of carboxypeptidase activity using the Nerita versicolor carboxypeptidase inhibitor (NvCI) dampened AHR and reduced goblet cell hyperplasia in a murine asthma model [18]. This evidence concerns the gene AHR and asthma.